title: [Role of dynamic contrast-enhanced MR mammography imaging in the diagnosis of breast tumors].
abstract: Potential of contrast-enhanced MR imaging (MRI) in diagnosis of breast tumors was studied in 112 patients aged 18-64 (76 suspects and 36--after combined treatment). The method proved highly-effective and specific--92 and 81%, respectively. The best timing was 3 months after surgery and 8 months after irradiation. No significant advantage of either one- or polymolar contrast agents was observed. MRI is highly efficient in diagnosing hypervascular formations, tumor grading and making prognosis. It is a method of choice in evaluating neoadjuvant polychemotherapy findings and combined treatment monitoring.
authors.forename: E K
authors.initials: EK
authors.lastname: Iakovleva
authors.forename: L A
authors.initials: LA
authors.lastname: Tiutin
authors.forename: K E
authors.initials: KE
authors.lastname: Tikhova
authors.forename: A V
authors.initials: AV
authors.lastname: Pozdniakov
authors.forename: E N
authors.initials: EN
authors.lastname: Shelkoplias
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003287:Contrast Media / Q000008:administration & dosage; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008327:Mammography / Q000379:methods*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D003287:Contrast Media